FDA Approves Amneal's Affordable Narcolepsy Drug

Amneal Pharmaceuticals receives FDA approval for its generic sodium oxybate, offering a more accessible and cost-effective treatment for narcolepsy's excessive sleepiness and cataplexy in patients 7+.